Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

A Meta Analysis of Distal Transradial Access vs. Conventional Transradial

Transradial access is currently the preferred access for diagnostic and therapeutic interventions. However, about 7% of patients experience radial artery occlusion (RAO), which is not expressed by clinical symptoms. However, RAO is a limit for future interventions; it reduces the potential use of that artery as a conduit for aorto-coronary bypass and for the creation of arterio-venous fistula for hemodialysis.

Función de la mano luego del acceso radial distal, ¿es seguro?

This is why distal transradial access has been introduced as an alternative for diagnostic and therapeutic procedures. Randomized studies have shown a lower rate of RAO with distal access.

The aim of this meta-analysis was to evaluate the effects of distal vs. conventional transradial access in angiographic and interventional procedures.

The primary endpoint (PEP) was RAO presence at follow-up. The secondary endpoint (SEP) was the presence of in-hospital RAO, in addition to local hematoma, radial spasm, time to successful radial artery puncture, number of radial puncture attempts, time to introducer insertion, amount of contrast administered, fluoroscopy time, and change in access.

There were 6208 patients included, from 14 randomized studies. Regarding the PEP, the use of distal transradial access was associated with a lower risk of RAO at follow-up up to 60 days (risk ratio [RR]: 0.36; 95% confidence interval [CI]: 0.23- 0.56; p < 0.001; number needed to treat [NNT] = 30), lower rate of in-hospital RAO (RR: 0.32; 95% CI: 0.19- 0.53; p < 0.001; NNT = 28), and lower rate of hematoma EASY ≥2 (RR: 0.51; 95% CI: 0.27 to 0.96; p = 0.04; NNT = 107).

Read also: Hand Function after Distal Radial Access: Is it Safe?

 Regarding the SEP, there were no differences in the rate of local hematoma, radial spasm, or hemostasis time. However, the use of distal transradial access was associated with longer radial artery puncture time (p < 0.001), longer introducer insertion time (p < 0.01), higher number of puncture attempts (p < 0.001), and higher rate of access change (p < 0.001).

Conclusion

This meta-analysis of randomized studies comparing distal vs. conventional transradial access among patients undergoing an angiographic study and/or therapeutic intervention showed that distal transradial access was associated with a lower risk of RAO and hematoma. However, it required more time for puncture and insertion of the introducer and more attempted punctures, and it resulted in high rates of access change.

Dr. Andrés Rodríguez.
Member of the editorial board of SOLACI.org.

Original Title: Distal vs Conventional Radial Access for Coronary Angiography and/or Intervention A Meta-Analysis of Randomized Trials.

Reference: Giuseppe Ferrante, MD, PHD et al J Am Coll Cardiol Intv 2022;15:2297–2311.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...